{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:38:58Z","timestamp":1790519938883,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.132","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T10:52:28Z","timestamp":1234003948000},"page":"2121-2127","source":"Crossref","is-referenced-by-count":23,"title":["A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Pin-Yu","family":"Perera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Kolibab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiki","family":"Momoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyanage P.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.01.132_bib1","unstructured":"http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.vaccine.2009.01.132_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.01.132_bib3","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Gu\u00e9rin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.01.132_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.01.132_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","article-title":"Defects in the interferon-gamma and interleukin-12 pathways","volume":"203","author":"Rosenzweig","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.01.132_bib6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14656566.5.3.581","article-title":"The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview","volume":"5","author":"Toussirot","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.vaccine.2009.01.132_bib7","series-title":"Current protocols in molecular biology","year":"2005"},{"key":"10.1016\/j.vaccine.2009.01.132_bib8","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.0630592100","article-title":"Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.01.132_bib9","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2009.01.132_bib10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.vaccine.2004.07.036","article-title":"A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis boosts BCG-induced protective immunity","volume":"23","author":"Derrick","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.132_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156652308784049363","article-title":"The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer","volume":"8","author":"G\u00f3mez","year":"2008","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2009.01.132_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib14","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1073\/pnas.0406649101","article-title":"IL-15\/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells","volume":"101","author":"Oh","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.01.132_bib15","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1128\/JVI.00538-07","article-title":"Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice","volume":"8","author":"Perera","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib16","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.4049\/jimmunol.165.8.4329","article-title":"IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses","volume":"165","author":"Hiroi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib17","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI34333","article-title":"Antibody association with HER-2\/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs","volume":"118","author":"Kim","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2009.01.132_bib18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1128\/IAI.66.4.1527-1533.1998","article-title":"Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection","volume":"66","author":"Denis","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.132_bib19","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib20","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.01.132_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0092-8674(88)90514-4","article-title":"Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein","volume":"52","author":"Bodmer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2009.01.132_bib22","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib23","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1371\/journal.pone.0001052","article-title":"Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials","volume":"2","author":"Pathan","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2009.01.132_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1286-4579(00)00329-4","article-title":"The role of interleukin 15 in mounting an immune response against microbial infections","volume":"2","author":"Yoshikai","year":"2000","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2009.01.132_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/eji.200535290","article-title":"Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells","volume":"36","author":"Rausch","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib26","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.4049\/jimmunol.181.10.7115","article-title":"IL-15 links TLR2\/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway","volume":"181","author":"Krutzik","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14760584.6.3.441","article-title":"Next generation: tuberculosis vaccines that elicit protective CD8+ T cells","volume":"6","author":"Behar","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.01.132_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/intimm\/dxg013","article-title":"IL-15 enhances the function and inhibits CD95\/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells","volume":"15","author":"Mueller","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2009.01.132_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates","volume":"116","author":"Picker","year":"2006","journal-title":"J Clin Invest"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:18:25Z","timestamp":1589548705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09002011"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.132","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}